Results 271 to 280 of about 844,715 (299)

Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial

Lancet, The, 2010
Patrick Royston
exaly  

Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial

Lancet, The, 2003
Tom Solomon, Bridget Wills, Nicholas J White   +2 more
exaly  

Pegunigalsidase Alfa-iwxj

American Journal of Health-System Pharmacy, 2023
openaire   +2 more sources

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

Lancet, The, 2014
Gregory J Dore, Graham R Foster, Michael W Fried   +2 more
exaly  

Alfa

Analytical Chemistry, 1991
openaire   +1 more source

Albutrepenonacog-alfa/nonacog-alfa

Reactions Weekly
openaire   +1 more source

Velmanase Alfa-tycv

American Journal of Health-System Pharmacy, 2023
openaire   +2 more sources

Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa

Lancet, The, 2000
Stanislas Pol
exaly  

Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection

New England Journal of Medicine, 2009
Mitchell N Davis, Mark S Sulkowski
exaly  

RECOMBINANT HUMAN INTERFERON ALFA-A SUPPRESSES HTLV-III REPLICATION IN VITRO

Lancet, The, 1985
Kevan Hartshorn
exaly